The Role of Xist in T Cell Activation and Female-Biased Autoimmunity
- Institution
- UNIVERSITY OF CALIFORNIA LOS ANGELES, CA
- Principal investigator
- Nicole M Wilkinson
- Funding
- $46K
- Duration
- 2025–2027
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Approximately 80% of individuals affected by autoimmune disease are female. While divergent sex hormones and chromosomes are known to contribute to sex bias, the roles of additional sex-specific factors are poorly understood. Xist, for instance, is a long non-coding RNA (lncRNA) expressed exclusively in females. Notably, Xist is more highly expressed in PBMCs from females with autoimmunity compared to healthy controls, suggesting a possible role for Xist in predisposing females to autoimmunity. Xist is a key regulator of X-linked gene expression, facilitating X chromosome inactivation (XCI) during early embryonic development. Recent work has identified Xist-mediated regulation of autosomal genes, a previously unappreciated Xist function, in cell types with atypical, dispersed Xist distribution. We and others have noted atypical, dispersed Xist in activated CD4+ T cells, an immune cell type critical in autoimmune pathogenesis. To study Xist in T cells and autoimmune pathogenesis, we engineered mice with T cell-specific Xist knockout. Preliminary studies reveal Xist-deficient CD4+ T cells are defective in proliferation and proinflammatory cytokine production, suggesting a critical role for Xist in T cell activation. However, the (1) mechanism by which Xist alters T cell effector function and (2) significance of Xist-driven phenotypic changes for autoimmune pathogenesis are not known. This proposal will test the hypothesis that Xist drives X-linked and autosomal chromatin accessibility and gene expression changes that support a proinflammatory T cell phenotype and contribute to female bias in autoimmunity. In Aim 1, we will perform ATAC-, RNA-, and RAP-sequencing in unstimulated and anti-CD3 stimulated Xist- deficient and WT CD4+ T cells to explore the mechanisms by which Xist regulates T cell effector function. In Aim 2, we will evaluate the role of T cell-intrinsic Xist in autoimmune pathogenesis using a mouse model of the female-biased, T cell-driven autoimmune disease, Sjogren’s Syndrome (SS). These studies will elucidate Xist function in T cells and explore T cell-intrinsic Xist as a potential determinant of female bias in autoimmunity. This work is guided by experts in T cell biology (Maureen Su, MD - sponsor; Gay Crooks, MD - thesis committee), lncRNA biology (Kathrin Plath, PhD - cosponsor), bioinformatics (Willy Hugo, PhD - collaborator), and sex differences in biology (Karen Reue, PhD – thesis committee) at the University of California Los Angeles. The trainee, Nicole Wilkinson, is richly supported for the work in this proposal and in reaching her career goal of running a translational immunology lab.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF CALIFORNIA LOS ANGELES
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of California Los Angeles71
Comparing surgical and endovascular arteriovenous fistula creation
Karen Woo · $306K · 2022–2026
- NIH · University of California Los Angeles66
Stimulation of novel spinal respiratory circuit to restore breathing in ventilator-dependent patients with SCI.
Daniel Lu · $1.1M · 2021–2027
- NIH · University of California Los Angeles53
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and ß-caryophyllene
Ziva D Cooper · $631K · 2020–2026